Disposition of 1000 shares by Adams Jonathan M of Biovie subject to Rule 16b-3
| BIVI Stock | USD 3.10 0.30 10.71% |
Under 56% of all Biovie's traders are looking to take a long position. The analysis of the overall investor sentiment regarding Biovie Inc suggests that some traders are interested. Biovie's investing sentiment shows overall attitude of investors towards Biovie Inc.
Biovie |
Filed transaction by Biovie Inc Officer: Evp Liver Cirrhosis Programs. Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
Read at finance.yahoo.com
 |
Biovie Fundamental Analysis
We analyze Biovie's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Biovie using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Biovie based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Working Capital
Working Capital Comparative Analysis
Biovie is currently under evaluation in working capital category among its peers. Working Capital is a measure of company efficiency and operating liquidity. The working capital is usually calculated by subtracting Current Liabilities from Current Assets. It is an important indicator of the firm ability to continue its normal operations without additional debt obligations. .
Biovie Inc Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Biovie stock to make a market-neutral strategy. Peer analysis of Biovie could also be used in its relative valuation, which is a method of valuing Biovie by comparing valuation metrics with similar companies.
Peers
Biovie Related Equities
| ABOS | Acumen Pharmaceuticals | 3.52 | ||||
| INZY | Inozyme Pharma | 2.95 | ||||
| HOOK | Hookipa Pharma | 2.38 | ||||
| MREO | Mereo BioPharma | 0.55 | ||||
| AMLX | Amylyx Pharmaceuticals | 0.18 | ||||
| DAWN | Day One | 0.65 | ||||
| TERN | Terns Pharmaceuticals | 1.44 | ||||
| XFOR | X4 Pharmaceuticals | 5.13 | ||||
| ELDN | Eledon Pharmaceuticals | 6.22 |
Complementary Tools for Biovie Stock analysis
When running Biovie's price analysis, check to measure Biovie's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Biovie is operating at the current time. Most of Biovie's value examination focuses on studying past and present price action to predict the probability of Biovie's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Biovie's price. Additionally, you may evaluate how the addition of Biovie to your portfolios can decrease your overall portfolio volatility.
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Stocks Directory Find actively traded stocks across global markets | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity |